Altimmune (ALT) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $95.6 million.
- Altimmune's Shares Outstanding rose 3441.05% to $95.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.6 million, marking a year-over-year increase of 3441.05%. This contributed to the annual value of $72.4 million for FY2024, which is 237.03% up from last year.
- Latest data reveals that Altimmune reported Shares Outstanding of $95.6 million as of Q3 2025, which was up 3441.05% from $85.1 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Shares Outstanding registered a high of $95.6 million during Q3 2025, and its lowest value of $38.3 million during Q1 2021.
- Its 5-year average for Shares Outstanding is $58.7 million, with a median of $52.7 million in 2023.
- Per our database at Business Quant, Altimmune's Shares Outstanding skyrocketed by 14907.83% in 2021 and then skyrocketed by 237.03% in 2024.
- Altimmune's Shares Outstanding (Quarter) stood at $41.0 million in 2021, then increased by 20.02% to $49.2 million in 2022, then surged by 43.65% to $70.7 million in 2023, then increased by 2.37% to $72.4 million in 2024, then surged by 32.13% to $95.6 million in 2025.
- Its Shares Outstanding was $95.6 million in Q3 2025, compared to $85.1 million in Q2 2025 and $77.8 million in Q1 2025.